Condition
Thermal Burns
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 3 (2)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06814717Phase 2RecruitingPrimary
A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns
NCT02278718Phase 3CompletedPrimary
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
NCT02148705Phase 3CompletedPrimary
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
NCT01638481CompletedPrimary
Chronology of Occult and Gross Coagulopathy in Burn Patients
NCT02059902Phase 4CompletedPrimary
Continuous Lidocaine Infusion for Management of Perioperative Burn Pain
Showing all 5 trials